Literature DB >> 1124533

Serial measurement of plasma cortisol in lung cancer.

I Lichter, N E Sirett.   

Abstract

Serial plasma cortisol estimations were carried out in 81 male lung cancer patients and in a control group of 50 male subjects with conditions other than lung cancer. It was found that group mean plasma cortisol levels, both in the morning and in the afternoon, were greater in the lung cancer patients than in the no-cancer control group. However, long-term assessment four years after the beginning of the study showed that high plasma cortisol levels were found predominantly in cancer patients within six months of death. If such patients are excluded from the study, there is no significant difference in group mean plasma cortisol levels between male lung cancer patients and a male control group.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124533      PMCID: PMC470250          DOI: 10.1136/thx.30.1.91

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  ADRENAL WIDTH AND METASTASIS IN BRONCHOGENIC CARCINOMA.

Authors:  G CARANASOS; B H RUEBNER
Journal:  Arch Pathol       Date:  1963-09

2.  ADRENOCORTICAL FUNCTION IN BRONCHOGENIC CARCINOMA: STUDY OF 100 PATIENTS.

Authors:  H B HATCH; A SEGALOFF; A OCHSNER
Journal:  Ann Surg       Date:  1965-05       Impact factor: 12.969

3.  Adrenocortical function in carcinoma of the lung.

Authors:  E E WERK; L J SHOLITON
Journal:  Cancer       Date:  1960 May-Jun       Impact factor: 6.860

4.  Metabolism of adrenal steroids in dying patients.

Authors:  A A SANDBERG; K EIK-NES; C J MIGEON; L T SAMUELS
Journal:  J Clin Endocrinol Metab       Date:  1956-08       Impact factor: 5.958

5.  Studies on adrenal cortical function in patients with lung cancer.

Authors:  A Kawai; M Tamura; S Tanimoto; H Honma; N Kuzuya
Journal:  Metabolism       Date:  1969-07       Impact factor: 8.694

6.  Plasma cortisol levels in lung cancer.

Authors:  I Lichter; N E Sirett
Journal:  Br Med J       Date:  1968-04-20

7.  Prognostic significance of a steroid-discriminant function in patients with inoperable lung cancer.

Authors:  L G Rao; M L Hewit
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

  7 in total
  4 in total

1.  Fenofibrate prevents skeletal muscle loss in mice with lung cancer.

Authors:  Marcus D Goncalves; Seo-Kyoung Hwang; Chantal Pauli; Charles J Murphy; Zhe Cheng; Benjamin D Hopkins; David Wu; Ryan M Loughran; Brooke M Emerling; Guoan Zhang; Douglas T Fearon; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung.

Authors:  M Hansen; M Hammer; L Hummer
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

3.  Estimation of cortisol levels in patients with premalignant disorders and oral squamous cell carcinoma.

Authors:  Priyanka Sharma; Simarpreet Virk Sandhu; Rajat Bhandari; Indu Verma; Ramanpreet Kaur Bhullar; Rajbir Kaur Khangura
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

4.  Identification of Novel Serum Metabolic Biomarkers as Indicators in the Progression of Intravenous Leiomyomatosis: A High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Study.

Authors:  Zhitong Ge; Penghui Feng; Zijuan Zhang; Jianchu Li; Qi Yu
Journal:  Front Cell Dev Biol       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.